Editor's Note A novel stem cell transplant treatment for sickle cell disease (SCD) led to disease-free outcomes for most participants in a clinical trial at a lower cost than gene therapy, according to a February 27 report in Sickle Cell Disease News. The approach, which relies on a less intensive…